CD14分子(CD14)活性蛋白
Active Cluster Of Differentiation 14 (CD14)
Monocyte differentiation antigen CD14; Myeloid cell-specific leucine-rich glycoprotein
- 编号APA685Hu01
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 缓冲液成份20mM Tris, 150mM NaCl缓冲液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性状冻干粉
- 纯度> 97%
- 等电点8.5
- 应用Cell culture; Activity Assays.
- 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 2016 ¥ 5040 ¥ 10080 ¥ 30240 ¥ 75600
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
活性实验
Figure. The binding activity of CD14 with LBP.
Cluster Of Differentiation 14 (CD14), also known as CD14, is a component of the innate immune system. CD14 acts as a co-receptor (along with the Toll-like receptor TLR 4 and MD-2) for the detection of bacterial lipopolysaccharide (LPS). CD14 can bind LPS only in the presence of lipopolysaccharide-binding protein (LBP). Although LPS is considered its main ligand, CD14 also recognizes other pathogen-associated molecular patterns such as lipoteichoic acid. Besides, Lipopolysaccharide Binding Protein (LBP) has been identified as an interactor of CD14, thus a binding ELISA assay was conducted to detect the interaction of recombinant human CD14 and recombinant human LBP. Briefly, CD14 were diluted serially in PBS with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to LBP-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-CD14 pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50µL stop solution to the wells and read at 450nm immediately. The binding activity of CD14 and LBP was shown in Figure 1, and this effect was in a dose dependent manner.
CD14 also can enhance LPS-stimulated IL-8 secretion by THP-1 human acute monocytic leukemia cells. Therefore, THP1 cells were cultured in 24 well plates at a concentration of 106 cells/mL and stimulated by LPS (1μg/mL), then added of different concentrations of recombinant human CD14 (1μg/mL, 5μg/mL). After 24h later, the production of IL8 was determined in the supernatants by cytokine specific ELISA.
Result: When the concentration of CD14 was 5μg/mL, the secretion LPS-stimulated IL-8 can be significantly increased.
The standard curve was demonstrated as follows.
Figure. Effects of CD14 on IL8 production by THP1 cells.
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
EPA685Hu62 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA685Hu62 | CD14分子(CD14)活性蛋白 | Cell culture; Activity Assays. |
APA685Hu01 | CD14分子(CD14)活性蛋白 | Cell culture; Activity Assays. |
RPA685Hu02 | CD14分子(CD14)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA685Hu01 | CD14分子(CD14)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA685Hu61 | CD14分子(CD14)活性蛋白 | Cell culture; Activity Assays. |
EPA685Hu61 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA685Hu64 | CD14分子(CD14)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA685Hu01 | CD14分子(CD14)多克隆抗体 | WB; IHC; ICC; IP. |
PAA685Hu06 | CD14分子(CD14)多克隆抗体 | WB; IHC; ICC; IP. |
PAA685Hu02 | CD14分子(CD14)多克隆抗体 | WB; IHC; ICC; IP. |
FAA685Hu01 | 抗CD14分子(CD14)多克隆抗体 | Flow cytometry. |
FAA685Hu03 | 抗CD14分子(CD14)多克隆抗体 | Flow cytometry. |
LAA685Hu71 | CD14分子(CD14)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAA685Hu27 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu29 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu23 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu22 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu21 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu24 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu25 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
MAA685Hu26 | CD14分子(CD14)单克隆抗体 | WB; IHC; ICC; IP. |
RAA685Hu25 | CD14分子(CD14)重组抗体 | WB; IF; ICC; IHC; IP; FCM. |
FAA685Hu02 | 抗CD14分子(CD14)单克隆抗体 | FCM |
FAA685Hu86 | 抗CD14分子(CD14)单克隆抗体(异硫氰酸荧光素标记) | FCM |
SEA685Hu | CD14分子(CD14)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMA685Hu | CD14分子(CD14)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
KSA685Hu01 | CD14分子(CD14)检测试剂盒DIY材料(酶联免疫吸附试验法) | Main materials for "Do It (ELISA Kit) Yourself". |
参考文献
杂志 | 参考文献 |
Journal of Pharmacology and Experimental Therapeutics | Successful Treatment of Acute Lung Injury with Pitavastatin in Septic Mice: Potential Role of Glucocorticoid Receptor Expression in Alveolar Macrophages [Aspet: 171462] |
Tumour Biol | Elevated serum soluble CD15 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma [PubMed: 26643894] |
Free Patents online | RHEUMATOID ARTHRITIS RELATED BIOMARKER [20170350884] |
Intensive Care Research | Evaluating the Roles of sCD14 and sCD14-ST in Diagnosing COPD and Predicting an Acute Exacerbation of COPD [] |